TRV-2026-2926Version 1 · Published

Saved · see the current record

Why this version exists

Certified into the record

The exact text we saved

This is the version exactly as it was saved, character for character. The SHA-256 hash below is a 64-character code worked out from that text. Run the same text through SHA-256 and you get the same code; change a single letter and the code comes out completely different. Each version also stores the previous version’s hash, which chains them together so no version can be swapped out quietly.

TRUVACE RECORD VERSION
record: TRV-2026-2926
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-11-15T00:02:49.577829Z
status: published
lens: g_space
sector: health
headline: AI-driven radiopharmaceutical dosimetry optimization for theranostics: a systematic review and meta-analysis
dek: Personalised radioligand therapy (RLT) depends on accurate absorbed-dose estimation. Standard dosimetry requires multiple post-therapy single-photon emission computed tomography/computed tomography (SPECT/CT) acquisitions, imposing logistical burdens. Machine learning (ML) and deep learning (DL) have been proposed to streamline organ segmentation, generate synthetic imaging timepoints, and predict patient-specific doses. We evaluated the performance, methodological quality, and translational readiness of artific…
gain_title: A systematic review of 58 studies covering 1,847 patients found AI cut median dosimetry processing time for radioligand therapy from 180 to 25 minutes, with pooled organ segmentation accuracy (Dice) of 0.87 on independent validation data.
problem_title: (none)
trace_subject: (none)
gain_reading: A systematic review of 58 studies covering 1,847 patients found AI cut median dosimetry processing time for radioligand therapy from 180 to 25 minutes, with pooled organ segmentation accuracy (Dice) of 0.87 on independent validation data.
gain_evidence: AI reduced median processing time from 180 to 25 minutes
problem_reading: (none)
problem_evidence: (none)
quick_read: A systematic review and meta-analysis of 58 studies covering 1,847 patients examined AI used to estimate absorbed radiation dose in radioligand therapy. Across the studies, AI reduced median processing time from 180 to 25 minutes.

Standard dosimetry needs several post-therapy SPECT/CT scans, which burdens patients and hospitals. AI methods aim to segment organs, generate synthetic imaging timepoints and predict patient-specific doses, which could ease that workload.

The evidence is still early. Most prediction studies carry a high risk of bias and few have external validation, so the findings show technical feasibility rather than proven benefit for patients.
limitation: 71% of prediction studies had high risk of bias, only four reported external validation, and most pooled outcomes were rated low or very low certainty, so the evidence shows technical feasibility rather than proven clinical utility.
tag: Evidence-backed gain
key_points: The review searched PubMed, Web of Science, Scopus and regional databases from January 2014 to March 2025 and included 58 studies with 1,847 patients (82% male). | Of those, 23 studies with independent validation sets entered the meta-analysis. | Pooled organ segmentation accuracy was a Dice coefficient of 0.87 (95% CI 0.83-0.90) across 16 studies. | Pooled voxel dosimetry relative absolute error was 6.1% (4.6-8.1%) across 12 studies. | Pretherapy kidney dose prediction reached a pooled concordance correlation coefficient of 0.79 (0.72-0.85) across 8 studies. | Cutting imaging from at least 3 scans to 1-2 scans raised relative absolute error by 8.2 percentage points (5.1-11.4).
rundown: Two reviewers screened studies and extracted data. Bias risk was assessed with PROBAST and QUADAS-2, and random-effects models limited to studies with independent validation pooled segmentation and dose prediction results.

On independent validation data, AI dosimetry showed promising accuracy for organ-level dose estimates and much shorter processing. Reducing the number of scans to one or two came at a cost of higher error, an increase of 8.2 percentage points.

The authors say PROBAST found high risk of bias in 71% of prediction studies, only four studies reported external validation, and most pooled outcomes were graded low or very low certainty. They call for multicentre external validation and prospective randomised trials comparing AI-guided with fixed-activity therapy before clinical adoption.
sources:
- peer_reviewed | Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) | https://doi.org/10.1016/j.remnie.2026.500374 | 2026-11-13
prev: 0000000000000000000000000000000000000000000000000000000000000000
SHA-256 hash
a2e1e4fb42c695629fb145583126c8f8f0038340ce08caac0403f867d4b9fd1b
Previous version’s hash
0000000000000000000000000000000000000000000000000000000000000000
Check this record hasn’t been altered
How to check it yourself, without trusting this page

Download any version from /api/record/TRV-2026-2926 and hash its canonical field yourself, for example with shasum -a 256. You should get its content_hash. Each version’s text also ends with prev:and the hash of the version before it (version 1 points to 64 zeros). If anyone had changed a single character of any version after it was saved, those hashes wouldn’t line up.